Safety and efficacy of Immune checkpoint Inhibitors (ICIs) plus chemotherapy versus chemotherapy alone for small cell lung cancer (SCLC): A systematic review and meta-analysis of randomized controlled trials

被引：0
|
作者：
Mu, Xiaohong [1 ]
Wang, Yunfang [2 ]
Fan, Zhengye [3 ]
Yi, Kang [2 ]
机构：
[1] Huanxian Peoples Hosp, Dept Cardiovasc Med, Qingyang 745700, Peoples R China
[2] Gansu Prov Hosp, Lanzhou 730000, Peoples R China
[3] First Hosp Longnan City, Longnan 742500, Peoples R China
来源：
ASIAN JOURNAL OF SURGERY | 2025年 / 48卷 / 01期
关键词：
ETOPOSIDE;
D O I：
10.1016/j.asjsur.2024.07.155
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：805 / 806
页数：2
相关论文
共 50 条
  • [1] The efficacy and safety of immune-checkpoint inhibitors plus chemotherapy versus chemotherapy for non-small cell lung cancer: An updated systematic review and meta-analysis
    Kang, Jing
    Zhang, Jun
    Tian, Zongsheng
    Xu, Ye
    Li, Jiangbi
    Li, Mingxian
    PLOS ONE, 2024, 19 (02):
  • [2] Efficacy and safety of immune checkpoint inhibitors combined with chemotherapy in patients with extensive-stage small cell lung cancer: a systematic review and meta-analysis of randomized controlled trials
    Chen, Chunlan
    Tian, Peng
    Zhong, Jiangshan
    Fan, Xianming
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [3] Safety evaluation of immune checkpoint inhibitors combined with chemotherapy for the treatment of small cell lung cancer: A meta-analysis of randomized controlled trials
    Longo, Vito
    Rizzo, Alessandro
    Catino, Annamaria
    Montrone, Michele
    Galetta, Domenico
    THORACIC CANCER, 2023, 14 (11) : 1029 - 1035
  • [4] EFFICACY AND SAFETY OF BEVACIZUMAB PLUS CHEMOTHERAPY VERSUS CHEMOTHERAPY ALONE IN THE TREATMENT OF NON-SMALL-CELL LUNG CANCER IN ASIAN PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Hyderboini, R. K.
    Vsn, M.
    Chidirala, S. R.
    Inuganti, B.
    Chakrawarthy, M.
    Belekar, V
    Dang, A.
    VALUE IN HEALTH, 2017, 20 (05) : A91 - A91
  • [5] PD-1/PD-L1 Inhibitors plus Chemotherapy Versus Chemotherapy Alone for Resectable Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Pasqualotto, Eric
    de Moraes, Francisco Cezar Aquino
    Chavez, Matheus Pedrotti
    Souza, Maria Eduarda Cavalcanti
    Rodrigues, Anna Luiza Soares de Oliveira
    Ferreira, Rafael Oliva Morgado
    Lopes, Lucca Moreira
    de Almeida, Artur Menegaz
    Fernandes, Marianne Rodrigues
    dos Santos, Ney Pereira Carneiro
    CANCERS, 2023, 15 (21)
  • [6] Immune checkpoint inhibitor plus chemotherapy versus chemotherapy alone in HER2-negative advanced gastric or gastroesophageal junction cancer: A systematic review and meta-analysis of randomized controlled trials
    Oliveira, Joao Pedro
    Mendes da Silva, Isadora Mamede
    de Liz, Caio Dabbous
    Maia, Melissa
    Ferreira de Oliveira, Audrey Cabral
    Fonseca Alves, Ana Caroline
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] Checkpoint inhibitors plus chemotherapy for first-line treatment of advanced non-small cell lung cancer: a systematic review and meta-analysis of randomized controlled trials
    Tun, Aung Myint
    Thein, Kyaw Zin
    LinThein, Wai
    Guevara, Elizabeth
    FUTURE SCIENCE OA, 2019, 5 (09):
  • [8] Clinical efficacy and safety of sodium cantharidinate plus chemotherapy in non-small-cell lung cancer: A systematic review and meta-analysis of 38 randomized controlled trials
    Xiao, Zheng
    Wang, Chengqiong
    Tan, Zhouke
    Hu, Shanshan
    Chen, Yali
    Zhou, Minghua
    Feng, Jihong
    Liu, Shiyu
    Chen, Ling
    Ding, Jie
    Gong, Qihai
    Tang, Fushan
    Liu, Hui
    Li, Xiaofei
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2019, 44 (01) : 23 - 38
  • [9] Efficacy and safety of immune checkpoint inhibitors (ICIs) in extensive-stage small cell lung cancer (SCLC)
    Xiaoting Ma
    Shan Wang
    Yujian Zhang
    Huamin Wei
    Jing Yu
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 593 - 606
  • [10] Immune checkpoint inhibitor plus chemotherapy versus chemotherapy alone as first-line for extensive stage small cell lung cancer: A meta-analysis
    Landre, T.
    Chouahnia, A. K.
    Des Guetz, G.
    Assie, J-B.
    Chouaid, C.
    ANNALS OF ONCOLOGY, 2020, 31 : S1041 - S1041
12345